4DMedical Limited (FDMDF)
OTCMKTS · Delayed Price · Currency is USD
2.190
-0.025 (-1.13%)
At close: Feb 6, 2026
4DMedical Market Cap
4DMedical has a market cap or net worth of $1.56 billion as of February 12, 2026. Its market cap has increased by 952.96% in one year.
Market Cap
1.56B
Enterprise Value
1.56B
Revenue
3.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.19
Market Cap Chart
Since August 7, 2020, 4DMedical's market cap has increased from 302.08M to 1.56B, an increase of 416.91%. That is a compound annual growth rate of 34.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.49B | 6.68% |
| Dec 31, 2025 | 1.40B | 1,044.31% |
| Dec 31, 2024 | 122.27M | -35.82% |
| Dec 29, 2023 | 190.51M | 126.48% |
| Dec 30, 2022 | 84.12M | -70.90% |
| Dec 31, 2021 | 289.07M | -41.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 337.95M |
| Tian'an Technology Group | 145.66M |
| Zomedica | 124.94M |
| Positron | 80.21M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 59.50M |
| Vivos | 31.43M |
| Guided Therapeutics | 28.51M |